Cannabis based drug is licensed for spasticity in patients with MS.

BMJ (Clinical research ed.)

Volumn 340, Issue , 2010, Pages

  Kmietowicz, Zosia ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID; CANNABIS; CHOLINERGIC RECEPTOR BLOCKING AGENT; PLANT EXTRACT; TETRAHYDROCANNABINOL CANNABIDIOL COMBINATION; TETRAHYDROCANNABINOL-CANNABIDIOL COMBINATION;

DRUG APPROVAL; HUMAN; MULTIPLE SCLEROSIS; NOTE; SPASTICITY;

CANNABINOIDS; CANNABIS; DRUG APPROVAL; HUMANS; MULTIPLE SCLEROSIS; MUSCLE SPASTICITY; PARASYMPATHOLYTICS; PLANT EXTRACTS;

EID: 77954598740     PISSN: None     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.c3363     Document Type: Note

References (0)